Human Polyclonal ApoA1 Ab
- Known as:
- Human Polyclonal ApoA1 Antibody
- Catalog number:
- a0334
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- ABclonal
- Gene target:
- Human Polyclonal ApoA1
Related genes to: Human Polyclonal ApoA1 Ab
- Gene:
- APOA1 NIH gene
- Name:
- apolipoprotein A1
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 11q23.3
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2019-04-23
Related products to: Human Polyclonal ApoA1 Ab
Related articles to: Human Polyclonal ApoA1 Ab
- Lipoprotein(a) [Lp(a)] and inflammation are critical drivers of residual risk. We aimed to evaluate the combined prognostic value of Lp(a) and a novel Inflammatory-Lipid Index [defined as hs-CRP × (ApoB/ApoA1)] in patients with acute coronary syndrome (ACS) and type 2 diabetes mellitus (T2DM). - Source: PubMed
Publication date: 2026/06/02
Li TingtingCong HongliangWang LinRuo WeiLi Wenyu - Cardiometabolic diseases (CMDs) are major contributors to global morbidity and mortality, and dietary bioactives such as polyphenols may modulate key risk factors. Olive by-products, particularly olive leaves (OL) and olive pomace (OP), are rich in phenolic compounds with antioxidant, anti-inflammatory, and cardiometabolic effects demonstrated across in vitro, preclinical, and clinical studies. - Source: PubMed
Publication date: 2026/06/06
Mansouri FatemehMardani MahnazRucci ChiaraBordoni LauraGabbianelli Rosita - This study aimed to evaluate clinical and laboratory indicators associated with varying cirrhosis severity, with the objective of supporting more accurate clinical assessment and stratification. - Source: PubMed
Chen JunLei Jia-BaoLi Jin-XinChen Guang-YaoSong Ying-HaoFeng Jun-An - Acute myeloid leukemia (AML) is a diverse malignant hematologic disorder with poor clinical outcomes. Increasing evidence suggests that metabolic reprogramming, particularly lipid metabolism, contributes to AML progression and may offer new opportunities for biomarker discovery and therapeutic targeting. However, lipid metabolism-related hub genes with diagnostic and prognostic relevance in AML have not been systematically characterized. - Source: PubMed
Publication date: 2026/05/29
Liu ChenchenPan YueyuanChen MingguiLi SongyuZhang Chong - The ratio of monocyte to apolipoprotein A1 (MAR) has emerged as a potential diagnostic marker for various chronic conditions, yet its utility in hepatocellular carcinoma (HCC) remains unexplored. This retrospective study aimed to evaluate the MAR's predictive capacity in HCC diagnosis and differentiation from hepatitis B virus (HBV) infection. - Source: PubMed
Publication date: 2026/03/27
Su ChengZhu XuefengLan JiaoLin ZhongyuanWei FuLi Ling